Search - tctmd.com

Displaying 481 - 500 of 1132

Sort: Relevancy | Date

News Daily News

Un Registro Alemán revela Tendencias en la Práctica CAS y Resultados a los 15 Años

Yael L. Maxwell

December 04, 2014

Presentation

Hybrid Revascularization for Multivessel CAD

Presenter: M Gasior

November 25, 2014

News Daily News

Being Refused CABG a Sign of Extra Risk for PCI Patients With Left Main, Multivessel Disease

L.A. McKeown

November 20, 2014

News Daily News

In-Hospital STEMI Deadlier, More Expensive Than Out-of-Hospital STEMI

November 19, 2014

News Daily News

SECURITY: 6 Months of DAPT Noninferior to 12 Months in Low-Risk Patients After PCI

Yael L. Maxwell

November 17, 2014

News Conference News AHA 2014

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

Yael L. Maxwell

November 17, 2014

News Daily News

Pobre Adherencia con Imágenes de Seguimiento Post-EVAR

L.A. McKeown

November 17, 2014

News Conference News AHA 2014

Vorapaxar Safe in NSTE-ACS But Bleeding Risk Merits 6-Month Delay Before Noncardiac Surgery

Yael L. Maxwell

November 16, 2014

Presentation AHA 2014

Efficacy and safety of vorapaxar in NSTE ACS patients undergoing non-cardiac surgery

Presenter: S. van Diepen

November 16, 2014

News Industry News

Medtronic Adds to Endurant 'AAA' Stent Graft System

November 11, 2014

News Daily News

El Debut de los SLF No logró Alterar el Beneficio sobre la Supervivencia de CABG frente a PCI en la Enfermedad Multivaso

L.A. McKeown

November 06, 2014

News Daily News

DES的问世没有改变CABG在多支血管治疗方面相对于PCI的优越性

L.A. McKeown

November 06, 2014

News Daily News

Debut of DES Failed to Alter Survival Benefit of CABG vs PCI in Multivessel Disease

L.A. McKeown

November 06, 2014

News Opinion Fellow Talk

Addressing the Gender Gap

Siddharth A. Wayangankar, MD, MPH

November 05, 2014

News Industry News

Medtronic Drug-Coated Balloon for Peripheral Artery Disease Also Benefits Patients with Diabetes in Landmark Study

November 03, 2014

Presentation

Impact of DES on the Comparative Effectiveness of CABG and PCI

Presenter: Mark A. Hlatky

November 03, 2014

News Features TCT 2014

Thoughtful Insights at TCT: Tackling Resistant Hypertension, Long SFA Lesions, and Complex Carotid Disease

Todd Neale

October 31, 2014

News Daily News

First-in-Human Transcatheter Mitral Valve Replacement Cases Show Safety, Efficacy

Yael L. Maxwell

October 24, 2014

News Industry News

Medtronic CoreValve System Shows Exceptional Outcomes and Valve Performance in TAVI Patients Treated Via Direct Aortic Access

October 13, 2014

News Daily News

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

October 10, 2014

Advertisement

Un Registro Alemán revela Tendencias en la Práctica CAS y Resultados a los 15 Años

Hybrid Revascularization for Multivessel CAD

Being Refused CABG a Sign of Extra Risk for PCI Patients With Left Main, Multivessel Disease

In-Hospital STEMI Deadlier, More Expensive Than Out-of-Hospital STEMI

SECURITY: 6 Months of DAPT Noninferior to 12 Months in Low-Risk Patients After PCI

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

Pobre Adherencia con Imágenes de Seguimiento Post-EVAR

Vorapaxar Safe in NSTE-ACS But Bleeding Risk Merits 6-Month Delay Before Noncardiac Surgery

Efficacy and safety of vorapaxar in NSTE ACS patients undergoing non-cardiac surgery

Medtronic Adds to Endurant 'AAA' Stent Graft System

El Debut de los SLF No logró Alterar el Beneficio sobre la Supervivencia de CABG frente a PCI en la Enfermedad Multivaso

DES的问世没有改变CABG在多支血管治疗方面相对于PCI的优越性

Debut of DES Failed to Alter Survival Benefit of CABG vs PCI in Multivessel Disease

Addressing the Gender Gap

Medtronic Drug-Coated Balloon for Peripheral Artery Disease Also Benefits Patients with Diabetes in Landmark Study

Impact of DES on the Comparative Effectiveness of CABG and PCI

Thoughtful Insights at TCT: Tackling Resistant Hypertension, Long SFA Lesions, and Complex Carotid Disease

First-in-Human Transcatheter Mitral Valve Replacement Cases Show Safety, Efficacy

Medtronic CoreValve System Shows Exceptional Outcomes and Valve Performance in TAVI Patients Treated Via Direct Aortic Access

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content